Yesterday the
New York Times revealed that 50 Afghan drug traffickers with ties to the Taliban were on the U.S. military’s “kill or capture” list. Today the Senate Foreign Relations Committee released
http://foreign.senate.gov/afghan.pdf">the report that the Times article was based on, adding further detail.
The 50 traffickers on the 367-strong target list are not subject to “targeted assassinations,” but U.S. and NATO troops do have authorization to kill or capture them if they’re encountered on the battlefield. The ruckus over the addition of drug traffickers to the kill-or-capture list points to the increased importance of the international community’s counternarcotics effort in the renewed effort in Afghanistan.
It’s become conventional wisdom that the Taliban receive large sums of money from the drug trade – the SFRC report cites military and UN estimates of between $70 million and $125 million a year in drug income. But conventional wisdom could be wrong. Ambassador Richard Holbrooke, the United States’ Special Representative for Afghanistan and Pakistan,
has stated on
more than one occasion that the Taliban’s primary source of funds are sympathizers in Persian Gulf states like Saudi Arabia, the UAE, and Qatar – not the illicit opium trade.
But this uncertainty over the opium trade’s role in funding the Taliban doesn’t mean the United States should give up on trying to tackle the problem. As the SFRC report shows, the Taliban use protection of the opium trade as a critical component of their establishment of a parallel government in parts of Afghanistan. In exchange for this protection, the Taliban extract taxes from opium farmers, heroin manufacturers, and drug traffickers.
more